Modafinil, a wakefulness-promoting agent, has gained vital consideration in each clinical and non-clinical settings. Originally authorised for the remedy of narcolepsy, obstructive sleep apnea, and shift work sleep disorder, modafinil has also become common off-label for its cognitive-enhancing results. This observational analysis article explores the availability and use of modafinil
